517.3K XNAS Volume
XNAS 19 Mar, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Timothy C. Dec | Senior Vice-President & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 2,000 | 12,898 (0%) | 0% | 0 | Common Stock | |
| Timothy C. Dec | Senior Vice-President & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 1,800 | 0 | - | - | Performance Share Unit | |
| Timothy C. Dec | Senior Vice-President & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 2,000 | 0 | - | - | Performance Share Unit | |
| Timothy C. Dec | Senior Vice-President & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.06 per share. | 10 Mar 2025 | 955 | 12,681 (0%) | 0% | 32.1 | 30,617 | Common Stock |
| Timothy C. Dec | Senior Vice-President & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 1,800 | 13,636 (0%) | 0% | 0 | Common Stock | |
| Timothy C. Dec | Senior Vice-President & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.06 per share. | 10 Mar 2025 | 1,062 | 11,836 (0%) | 0% | 32.1 | 34,048 | Common Stock |
| Jack A. Khattar | Director, President, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.06 per share. | 10 Mar 2025 | 16,805 | 991,833 (1%) | 0% | 32.1 | 538,768 | Common Stock |
| Jack A. Khattar | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 35,000 | 0 | - | - | Performance Share Unit | |
| Jack A. Khattar | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 35,000 | 1,008,638 (1%) | 0% | 0 | Common Stock | |
| Jack A. Khattar | Director, President, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.11 per share. | 07 Mar 2025 | 18,581 | 973,638 (1%) | 0% | 39.1 | 726,703 | Common Stock |
| Jack A. Khattar | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2025 | 38,640 | 0 | - | - | Performance Share Units | |
| Jack A. Khattar | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2025 | 38,640 | 992,219 (1%) | 0% | 0 | Common Stock | |
| Frank Mottola | SVP, Quality, GMP, Ops, IT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.11 per share. | 07 Mar 2025 | 1,356 | 15,151 (0%) | 0% | 39.1 | 53,033 | Common Stock |
| Frank Mottola | SVP, Quality, GMP, Ops, IT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2025 | 2,625 | 0 | - | - | Performance Share Units | |
| Frank Mottola | SVP, Quality, GMP, Ops, IT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2025 | 2,625 | 16,507 (0%) | 0% | 0 | Common Stock | |
| Timothy C. Dec | Senior Vice-President & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.05 per share. | 05 Mar 2025 | 276 | 13,815 (0%) | 0% | 33.1 | 9,122 | Common Stock |
| Timothy C. Dec | Senior Vice-President & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.05 per share. | 05 Mar 2025 | 1,330 | 10,898 (0%) | 0% | 33.1 | 43,957 | Common Stock |
| Timothy C. Dec | Senior Vice-President & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.05 per share. | 05 Mar 2025 | 1,587 | 12,228 (0%) | 0% | 33.0 | 52,450 | Common Stock |
| Padmanabh P. Bhatt | Sr. VP of IP, CSO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.05 per share. | 05 Mar 2025 | 575 | 12,704 (0%) | 0% | 33.1 | 19,004 | Common Stock |
| Padmanabh P. Bhatt | Sr. VP of IP, CSO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.05 per share. | 05 Mar 2025 | 575 | 13,279 (0%) | 0% | 33.1 | 19,004 | Common Stock |
| Padmanabh P. Bhatt | Sr. VP of IP, CSO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.05 per share. | 05 Mar 2025 | 335 | 13,854 (0%) | 0% | 33.1 | 11,072 | Common Stock |
| Jonathan Rubin | SVP, Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.05 per share. | 05 Mar 2025 | 577 | 10,212 (0%) | 0% | 33.1 | 19,070 | Common Stock |
| Jonathan Rubin | SVP, Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.05 per share. | 05 Mar 2025 | 577 | 9,635 (0%) | 0% | 33.1 | 19,070 | Common Stock |
| Jonathan Rubin | SVP, Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.05 per share. | 05 Mar 2025 | 314 | 10,789 (0%) | 0% | 33.1 | 10,378 | Common Stock |
| Frank Mottola | SVP, Quality, GMP, Ops, IT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.05 per share. | 05 Mar 2025 | 337 | 15,437 (0%) | 0% | 33.1 | 11,138 | Common Stock |
| Frank Mottola | SVP, Quality, GMP, Ops, IT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.05 per share. | 05 Mar 2025 | 945 | 13,882 (0%) | 0% | 33.0 | 31,232 | Common Stock |
| Frank Mottola | SVP, Quality, GMP, Ops, IT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.05 per share. | 05 Mar 2025 | 610 | 14,827 (0%) | 0% | 33.1 | 20,161 | Common Stock |
| Timothy C. Dec | Senior Vice-President & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 1,800 | 1,800 | - | - | Performance Share Unit | |
| Timothy C. Dec | Senior Vice-President & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 2,000 | 2,000 | - | - | Performance Share Unit | |
| Jack A. Khattar | Director, President, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 35,000 | 35,000 | - | - | Performance Share Unit | |
| Frank Mottola | SVP, Quality, GMP, Ops, IT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.48 per share. | 26 Feb 2025 | 976 | 13,933 (0%) | 0% | 39.5 | 38,532 | Common Stock |
| Frank Mottola | SVP, Quality, GMP, Ops, IT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2025 | 3,750 | 0 | - | - | Performance Share Units | |
| Frank Mottola | SVP, Quality, GMP, Ops, IT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2025 | 2,010 | 0 | - | - | Performance Share Units | |
| Frank Mottola | SVP, Quality, GMP, Ops, IT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.48 per share. | 26 Feb 2025 | 1,909 | 15,774 (0%) | 0% | 39.5 | 75,367 | Common Stock |
| Frank Mottola | SVP, Quality, GMP, Ops, IT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2025 | 3,750 | 17,683 (0%) | 0% | 0 | Common Stock | |
| Frank Mottola | SVP, Quality, GMP, Ops, IT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2025 | 2,010 | 14,909 (0%) | 0% | 0 | Common Stock | |
| Charles W. Newhall | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Feb 2025 | 5,369 | 0 | - | - | Restricted Stock Units | |
| Charles W. Newhall | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2025 | 5,369 | 135,644 (0%) | 0% | 0 | Common Stock | |
| Frederick M. Hudson | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Feb 2025 | 5,369 | 0 | - | - | Restricted Stock Units | |
| Frederick M. Hudson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2025 | 5,369 | 53,764 (0%) | 0% | 0 | Common Stock | |
| Georges Gemayel | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Feb 2025 | 5,369 | 0 | - | - | Restricted Stock Units | |
| Georges Gemayel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2025 | 5,369 | 18,684 (0%) | 0% | 0 | Common Stock | |
| Timothy C. Dec | Senior Vice-President & CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Feb 2025 | 3,000 | 9,000 | - | - | Restricted Stock Unit | |
| Timothy C. Dec | Senior Vice-President & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2025 | 3,000 | 11,591 (0%) | 0% | 0 | Common Stock | |
| Timothy C. Dec | Senior Vice-President & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2025 | 2,500 | 14,091 (0%) | 0% | 0 | Common Stock | |
| Timothy C. Dec | Senior Vice-President & CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Feb 2025 | 500 | 500 | - | - | Restricted Stock Unit | |
| Timothy C. Dec | Senior Vice-President & CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Feb 2025 | 2,500 | 5,000 | - | - | Restricted Stock Unit | |
| Timothy C. Dec | Senior Vice-President & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2025 | 500 | 8,591 (0%) | 0% | 0 | Common Stock | |
| Carrolee Barlow | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Feb 2025 | 5,369 | 0 | - | - | Restricted Stock Units | |
| Carrolee Barlow | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2025 | 5,369 | 22,570 (0%) | 0% | 0 | Common Stock | |
| Bethany Sensenig | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2025 | 5,369 | 5,369 (0%) | 0% | 0 | Common Stock | |
| Bethany Sensenig | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Feb 2025 | 5,369 | 0 | - | - | Restricted Stock Units | |
| Padmanabh P. Bhatt | Sr. VP of IP, CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2025 | 750 | 11,689 (0%) | 0% | 0 | Common Stock | |
| Padmanabh P. Bhatt | Sr. VP of IP, CSO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Feb 2025 | 1,250 | 2,500 | - | - | Restricted Stock Unit | |
| Padmanabh P. Bhatt | Sr. VP of IP, CSO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Feb 2025 | 1,250 | 3,750 | - | - | Restricted Stock Unit | |
| Padmanabh P. Bhatt | Sr. VP of IP, CSO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Feb 2025 | 750 | 750 | - | - | Restricted Stock Unit | |
| Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2025 | 1,650 | 0 | - | - | Performance Share Units | |
| Padmanabh P. Bhatt | Sr. VP of IP, CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2025 | 1,250 | 14,189 (0%) | 0% | 0 | Common Stock | |
| Padmanabh P. Bhatt | Sr. VP of IP, CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2025 | 1,250 | 12,939 (0%) | 0% | 0 | Common Stock | |
| Padmanabh P. Bhatt | Sr. VP of IP, CSO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.15 per share. | 21 Feb 2025 | 860 | 10,939 (0%) | 0% | 39.2 | 33,669 | Common Stock |
| Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2025 | 1,650 | 11,799 (0%) | 0% | 0 | Common Stock | |
| Jonathan Rubin | SVP, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2025 | 1,250 | 9,853 (0%) | 0% | 0 | Common Stock | |
| Jonathan Rubin | SVP, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2025 | 1,250 | 11,103 (0%) | 0% | 0 | Common Stock | |
| Jonathan Rubin | SVP, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2025 | 1,875 | 0 | - | - | Performance Share Units | |
| Jonathan Rubin | SVP, Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Feb 2025 | 1,250 | 2,500 | - | - | Restricted Stock Unit | |
| Jonathan Rubin | SVP, Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Feb 2025 | 750 | 750 | - | - | Restricted Stock Unit | |
| Jonathan Rubin | SVP, Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Feb 2025 | 1,250 | 3,750 | - | - | Restricted Stock Unit | |
| Jonathan Rubin | SVP, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2025 | 1,875 | 8,780 (0%) | 0% | 0 | Common Stock | |
| Jonathan Rubin | SVP, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 39.15 per share. | 21 Feb 2025 | 927 | 7,853 (0%) | 0% | 39.1 | 36,292 | Common Stock |
| Jonathan Rubin | SVP, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2025 | 750 | 8,603 (0%) | 0% | 0 | Common Stock | |
| Frank Mottola | SVP, Quality, GMP, Ops, IT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2025 | 1,125 | 0 | - | - | Performance Share Units | |
| Frank Mottola | SVP, Quality, GMP, Ops, IT | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Feb 2025 | 750 | 750 | - | - | Restricted Stock Unit | |
| Frank Mottola | SVP, Quality, GMP, Ops, IT | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Feb 2025 | 1,250 | 3,750 | - | - | Restricted Stock Unit | |
| Frank Mottola | SVP, Quality, GMP, Ops, IT | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Feb 2025 | 1,875 | 3,750 | - | - | Restricted Stock Unit | |
| Frank Mottola | SVP, Quality, GMP, Ops, IT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.15 per share. | 21 Feb 2025 | 552 | 9,024 (0%) | 0% | 39.2 | 21,611 | Common Stock |
| Frank Mottola | SVP, Quality, GMP, Ops, IT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2025 | 1,125 | 9,576 (0%) | 0% | 0 | Common Stock | |
| Frank Mottola | SVP, Quality, GMP, Ops, IT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2025 | 750 | 9,774 (0%) | 0% | 0 | Common Stock | |
| Frank Mottola | SVP, Quality, GMP, Ops, IT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2025 | 1,250 | 11,024 (0%) | 0% | 0 | Common Stock | |
| Frank Mottola | SVP, Quality, GMP, Ops, IT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2025 | 1,875 | 12,899 (0%) | 0% | 0 | Common Stock | |
| Jack A. Khattar | Director, President, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 331,660 | 331,660 | - | - | Employee Stock Option (Right to Buy) | |
| Charles W. Newhall | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2025 | 4,475 | 4,475 | - | - | Restricted Stock Unit | |
| Charles W. Newhall | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2025 | 7,296 | 7,296 | - | - | Director Stock Option (Right to Buy) | |
| Frederick M. Hudson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2025 | 4,475 | 4,475 | - | - | Restricted Stock Unit | |
| Frederick M. Hudson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2025 | 7,296 | 7,296 | - | - | Director Stock Option (Right to Buy) | |
| Georges Gemayel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2025 | 4,475 | 4,475 | - | - | Restricted Stock Unit | |
| Georges Gemayel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2025 | 7,296 | 7,296 | - | - | Director Stock Option (Right to Buy) | |
| Timothy C. Dec | Senior Vice-President & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2025 | 4,500 | 4,500 | - | - | Restricted Stock Unit | |
| Timothy C. Dec | Senior Vice-President & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2025 | 40,000 | 40,000 | - | - | Employee Stock Option (Right to Buy) | |
| Padmanabh P. Bhatt | Sr. VP of IP, CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2025 | 20,000 | 20,000 | - | - | Employee Stock Option (Right to Buy) | |
| Padmanabh P. Bhatt | Sr. VP of IP, CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2025 | 4,500 | 4,500 | - | - | Restricted Stock Unit | |
| Jonathan Rubin | SVP, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2025 | 4,500 | 4,500 | - | - | Restricted Stock Unit | |
| Jonathan Rubin | SVP, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2025 | 20,000 | 20,000 | - | - | Employee Stock Option (Right to Buy) | |
| Carrolee Barlow | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2025 | 4,475 | 4,475 | - | - | Restricted Stock Unit | |
| Carrolee Barlow | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2025 | 7,296 | 7,296 | - | - | Director Stock Option (Right to Buy) | |
| Frank Mottola | SVP, Quality, GMP, Ops, IT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2025 | 4,500 | 4,500 | - | - | Restricted Stock Unit | |
| Frank Mottola | SVP, Quality, GMP, Ops, IT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2025 | 20,000 | 20,000 | - | - | Employee Stock Option (Right to Buy) | |
| Bethany Sensenig | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2025 | 4,475 | 4,475 | - | - | Restricted Stock Unit | |
| Bethany Sensenig | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2025 | 7,296 | 7,296 | - | - | Director Stock Option (Right to Buy) | |
| Jack A. Khattar | Director, President, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2025 | 38,640 | 38,640 | - | - | Performance Share Units | |
| Frank Mottola | SVP, Quality, GMP, Ops, IT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2025 | 2,625 | 2,625 | - | - | Performance Share Units | |
| Frank Mottola | SVP, Quality, GMP, Ops, IT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2025 | 2,010 | 2,010 | - | - | Performance Share Units | |
| Frank Mottola | SVP, Quality, GMP, Ops, IT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2025 | 3,750 | 3,750 | - | - | Performance Share Units | |
| Padmanabh P. Bhatt | Sr. VP of IP, CSO | Sale of securities on an exchange or to another person at price $ 39.70 per share. | 04 Feb 2025 | 9,477 | 10,149 (0%) | 0% | 39.7 | 376,237 | Common Stock |
| Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 29.61 per share. | 04 Feb 2025 | 9,477 | 19,626 (0%) | 0% | 29.6 | 280,614 | Common Stock |
| Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Feb 2025 | 9,477 | 4,250 | - | - | Employee Stock Option (Right to Buy) | |
| Jonathan Rubin | SVP, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2025 | 1,875 | 1,875 | - | - | Performance Share Units | |
| Frank Mottola | SVP, Quality, GMP, Ops, IT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2025 | 1,125 | 1,125 | - | - | Performance Share Units | |
| Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jan 2025 | 700 | 13,727 | - | - | Employee Stock Option (Right to Buy) | |
| Padmanabh P. Bhatt | Sr. VP of IP, CSO | Sale of securities on an exchange or to another person at price $ 39.62 per share. | 27 Jan 2025 | 700 | 10,149 (0%) | 0% | 39.6 | 27,734 | Common Stock |
| Padmanabh P. Bhatt | Sr. VP of IP, CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 1,650 | 1,650 | - | - | Performance Share Units | |
| Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2025 | 700 | 9,477 | - | - | Employee Stock Option (Right to Buy) | |
| Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2025 | 2,573 | 10,177 | - | - | Employee Stock Option (Right to Buy) | |
| Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 29.61 per share. | 27 Jan 2025 | 2,573 | 12,722 (0%) | 0% | 29.6 | 76,187 | Common Stock |
| Padmanabh P. Bhatt | Sr. VP of IP, CSO | Sale of securities on an exchange or to another person at price $ 39.62 per share. | 27 Jan 2025 | 2,573 | 10,149 (0%) | 0% | 39.6 | 101,942 | Common Stock |
| Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 29.61 per share. | 27 Jan 2025 | 700 | 10,849 (0%) | 0% | 29.6 | 20,727 | Common Stock |
| Frederick M. Hudson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.13 per share. | 22 Jan 2025 | 20,000 | 48,395 (0%) | 0% | 9.1 | 182,600 | Common Stock |
| Frederick M. Hudson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jan 2025 | 20,000 | 0 | - | - | Director Stock Option (Right to Buy) | |
| Khattar A. Jack | Director, President, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.59 per share. | 27 Dec 2024 | 18,567 | 946,245 (1%) | 0% | 35.6 | 660,800 | Common Stock |
| Rubin Jonathan | SVP, Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.59 per share. | 27 Dec 2024 | 281 | 5,541 (0%) | 0% | 35.6 | 10,001 | Common Stock |
| Jonathan Rubin | SVP, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Dec 2024 | 750 | 5,822 (0%) | 0% | 0 | Common Stock | |
| Rubin Jonathan | SVP, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Dec 2024 | 1,875 | 7,416 (0%) | 0% | 0 | Common Stock | |
| Jack A. Khattar | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Dec 2024 | 38,640 | 964,812 (1%) | 0% | 0 | Common Stock | |
| Khattar Jack A. | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Dec 2024 | 38,640 | 0 | - | - | Performance Share Unit | |
| Jonathan Rubin | SVP, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Dec 2024 | 750 | 0 | - | - | Performance Share Unit | |
| Jack A. Khattar | Director, President, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.59 per share. | 27 Dec 2024 | 6,666 | 953,579 (1%) | 0% | 35.6 | 237,243 | Common Stock |
| Jack A. Khattar | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Dec 2024 | 14,000 | 960,245 (1%) | 0% | 0 | Common Stock | |
| Jonathan Rubin | SVP, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Dec 2024 | 1,875 | 0 | - | - | Performance Share Unit | |
| Rubin Jonathan | SVP, Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.59 per share. | 27 Dec 2024 | 821 | 6,595 (0%) | 0% | 35.6 | 29,219 | Common Stock |
| Khattar Jack A. | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Dec 2024 | 14,000 | 0 | - | - | Performance Share Unit | |
| Rubin Jonathan | SVP, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2024 | 750 | 750 | - | - | Performance Share Unit | |
| Jonathan Rubin | SVP, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2024 | 1,875 | 1,875 | - | - | Performance Share Unit | |
| Jack A. Khattar | Director, President, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2024 | 14,000 | 14,000 | - | - | Performance Share Unit | |
| A. Jack Khattar | Director, President, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2024 | 38,640 | 38,640 | - | - | Performance Share Unit | |
| Bhatt P. Padmanabh | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Dec 2024 | 8,750 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Bhatt Padmanabh P. | Sr. VP of IP, CSO | Sale of securities on an exchange or to another person at price $ 36.68 per share. | 03 Dec 2024 | 12,745 | 9,679 (0%) | 0% | 36.7 | 467,487 | Common Stock |
| Padmanabh Bhatt P. | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.99 per share. | 03 Dec 2024 | 8,750 | 18,429 (0%) | 0% | 24.0 | 209,913 | Common Stock |
| P. Bhatt Padmanabh | Sr. VP of IP, CSO | Sale of securities on an exchange or to another person at price $ 36.68 per share. | 03 Dec 2024 | 8,750 | 9,679 (0%) | 0% | 36.7 | 320,950 | Common Stock |
| Bhatt P. Padmanabh | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 25.30 per share. | 03 Dec 2024 | 12,745 | 22,424 (0%) | 0% | 25.3 | 322,449 | Common Stock |
| P. Padmanabh Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Dec 2024 | 12,745 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Charles W. Newhall | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Nov 2024 | 20,000 | 0 | - | - | Director Stock Option (Right to Buy) | |
| Charles W. Newhall | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.13 per share. | 11 Nov 2024 | 20,000 | 140,975 (0%) | 0% | 9.1 | 182,600 | Common Stock |
| Charles W. Newhall | Director | Sale of securities on an exchange or to another person at price $ 36.24 per share. | 11 Nov 2024 | 10,700 | 130,275 (0%) | 0% | 36.2 | 387,768 | Common Stock |
| Frederick M. Hudson | Director | Sale of securities on an exchange or to another person at price $ 36.28 per share. | 08 Nov 2024 | 8,722 | 28,395 (0%) | 0% | 36.3 | 316,434 | Common Stock |
| Georges Gemayel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Nov 2024 | 10,787 | 0 | - | - | Director Stock Option (Right to Buy) | |
| Georges Gemayel | Director | Sale of securities on an exchange or to another person at price $ 36.30 per share. | 08 Nov 2024 | 10,787 | 13,315 (0%) | 0% | 36.3 | 391,568 | Common Stock |
| Georges Gemayel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.46 per share. | 08 Nov 2024 | 10,787 | 24,102 (0%) | 0% | 11.5 | 123,619 | Common Stock |
| Jack A. Khattar | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.13 per share. | 08 Nov 2024 | 125,000 | 1,051,172 (2%) | 0% | 9.1 | 1,141,250 | Common Stock |
| Jack A. Khattar | Director, President, CEO | Sale of securities on an exchange or to another person at price $ 36.29 per share. | 08 Nov 2024 | 125,000 | 926,172 (1%) | 0% | 36.3 | 4,536,250 | Common Stock |
| Jack A. Khattar | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Nov 2024 | 125,000 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Georges Gemayel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2024 | 14,213 | 10,787 | - | - | Director Stock Option (Right to Buy) | |
| Georges Gemayel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.46 per share. | 07 Nov 2024 | 14,213 | 27,528 (0%) | 0% | 11.5 | 162,881 | Common Stock |
| Georges Gemayel | Director | Sale of securities on an exchange or to another person at price $ 36.62 per share. | 07 Nov 2024 | 14,213 | 13,315 (0%) | 0% | 36.6 | 520,480 | Common Stock |
| Jack A. Khattar | Director, President, CEO | Sale of securities on an exchange or to another person at price $ 36.68 per share. | 07 Nov 2024 | 125,000 | 926,172 (1%) | 0% | 36.7 | 4,585,000 | Common Stock |
| Jack A. Khattar | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2024 | 125,000 | 125,000 | - | - | Employee Stock Option (Right to Buy) | |
| Jack A. Khattar | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.13 per share. | 07 Nov 2024 | 125,000 | 1,051,172 (2%) | 0% | 9.1 | 1,141,250 | Common Stock |
| Frank Mottola | SVP, Quality, GMP, Ops, IT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.13 per share. | 07 Nov 2024 | 15,000 | 23,200 (0%) | 0% | 9.1 | 136,950 | Common Stock |
| Frank Mottola | SVP, Quality, GMP, Ops, IT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2024 | 15,000 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Frank Mottola | SVP, Quality, GMP, Ops, IT | Sale of securities on an exchange or to another person at price $ 36.98 per share. | 07 Nov 2024 | 15,000 | 8,200 (0%) | 0% | 37.0 | 554,700 | Common Stock |
| Georges Gemayel | Director | Sale of securities on an exchange or to another person at price $ 31.33 per share. | 13 Sep 2024 | 3,886 | 13,315 (0%) | 0% | 31.3 | 121,748 | Common Stock |
| Georges Gemayel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Sep 2024 | 10,000 | 25,000 | - | - | Director Stock Option (Right to Buy) | |
| Georges Gemayel | Director | Sale of securities on an exchange or to another person at price $ 31.33 per share. | 13 Sep 2024 | 10,000 | 13,315 (0%) | 0% | 31.3 | 313,300 | Common Stock |
| Georges Gemayel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.46 per share. | 13 Sep 2024 | 10,000 | 23,315 (0%) | 0% | 11.5 | 114,600 | Common Stock |
| Jack A. Khattar | Director, President, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.90 per share. | 03 Sep 2024 | 10,045 | 926,172 (1%) | 0% | 34.9 | 350,571 | Common Stock |
| Jack A. Khattar | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Sep 2024 | 21,000 | 0 | - | - | Performance Share Unit | |
| Jack A. Khattar | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Sep 2024 | 21,000 | 936,217 (1%) | 0% | 0 | Common Stock | |
| Jack A. Khattar | Director, President, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Aug 2024 | 21,000 | 21,000 | - | - | Performance Share Unit | |
| Padmanabh P. Bhatt | Sr. VP of IP, CSO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.57 per share. | 20 Aug 2024 | 572 | 9,679 (0%) | 0% | 29.6 | 16,914 | Common Stock |
| Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Aug 2024 | 1,250 | 0 | - | - | Performance Share Unit | |
| Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Aug 2024 | 1,250 | 10,251 (0%) | 0% | 0 | Common Stock | |
| Padmanabh P. Bhatt | Sr. VP of IP, CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2024 | 1,250 | 1,250 | - | - | Performance Share Unit | |
| Padmanabh P. Bhatt | Sr. VP of IP, CSO | Sale of securities on an exchange or to another person at price $ 35.31 per share. | 21 Mar 2024 | 14,491 | 8,570 (0%) | 0% | 35.3 | 511,677 | Common Stock |
| Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Mar 2024 | 14,491 | 12,745 | - | - | Employee Stock Option (Right to Buy) | |
| Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 25.30 per share. | 21 Mar 2024 | 14,491 | 23,061 (0%) | 0% | 25.3 | 366,622 | Common Stock |
| Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Mar 2024 | 400 | 27,236 | - | - | Employee Stock Option (Right to Buy) | |
| Padmanabh P. Bhatt | Sr. VP of IP, CSO | Sale of securities on an exchange or to another person at price $ 35.31 per share. | 20 Mar 2024 | 400 | 8,570 (0%) | 0% | 35.3 | 14,124 | Common Stock |
| Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 25.30 per share. | 20 Mar 2024 | 400 | 8,970 (0%) | 0% | 25.3 | 10,120 | Common Stock |
| Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 25.30 per share. | 19 Mar 2024 | 12,364 | 20,934 (0%) | 0% | 25.3 | 312,809 | Common Stock |
| Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Mar 2024 | 12,364 | 27,636 | - | - | Employee Stock Option (Right to Buy) | |
| Padmanabh P. Bhatt | Sr. VP of IP, CSO | Sale of securities on an exchange or to another person at price $ 35.31 per share. | 19 Mar 2024 | 12,364 | 8,570 (0%) | 0% | 35.3 | 436,573 | Common Stock |
| Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.99 per share. | 13 Mar 2024 | 26,250 | 34,820 (0%) | 0% | 24.0 | 629,738 | Common Stock |
| Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Mar 2024 | 36,116 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Mar 2024 | 26,250 | 8,750 | - | - | Employee Stock Option (Right to Buy) | |
| Padmanabh P. Bhatt | Sr. VP of IP, CSO | Sale of securities on an exchange or to another person at price $ 33.48 per share. | 13 Mar 2024 | 36,116 | 8,570 (0%) | 0% | 33.5 | 1,209,164 | Common Stock |
| Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.98 per share. | 13 Mar 2024 | 36,116 | 44,686 (0%) | 0% | 13.0 | 468,786 | Common Stock |
| Padmanabh P. Bhatt | Sr. VP of IP, CSO | Sale of securities on an exchange or to another person at price $ 34.10 per share. | 13 Mar 2024 | 26,250 | 8,570 (0%) | 0% | 34.1 | 895,125 | Common Stock |
| Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.98 per share. | 12 Mar 2024 | 3,884 | 12,454 (0%) | 0% | 13.0 | 50,414 | Common Stock |
| Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2024 | 3,884 | 36,116 | - | - | Employee Stock Option (Right to Buy) | |
| Padmanabh P. Bhatt | Sr. VP of IP, CSO | Sale of securities on an exchange or to another person at price $ 32.99 per share. | 12 Mar 2024 | 3,884 | 8,570 (0%) | 0% | 33.0 | 128,133 | Common Stock |
| Mottola Frank | SVP, Quality, GMP, Ops, IT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2024 | 990 | 8,239 (0%) | 0% | 0 | Common Stock | |
| Khattar Jack A. | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2024 | 35,000 | 0 | - | - | Performance Share Unit | |
| Mottola Frank | SVP, Quality, GMP, Ops, IT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2024 | 990 | 0 | - | - | Performance Share Unit | |
| A. Jack Khattar | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2024 | 35,000 | 932,005 (1%) | 0% | 0 | Common Stock | |
| Jack A. Khattar | Director, President, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.94 per share. | 28 Feb 2024 | 16,788 | 915,217 (1%) | 0% | 27.9 | 469,057 | Common Stock |
| Frank Mottola | SVP, Quality, GMP, Ops, IT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.94 per share. | 28 Feb 2024 | 460 | 7,779 (0%) | 0% | 27.9 | 12,852 | Common Stock |
| Bhatt Padmanabh P. | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2024 | 5,000 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| P. Bhatt Padmanabh | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.13 per share. | 26 Feb 2024 | 5,000 | 13,570 (0%) | 0% | 9.1 | 45,650 | Common Stock |
| Padmanabh Bhatt P. | Sr. VP of IP, CSO | Sale of securities on an exchange or to another person at price $ 30.21 per share. | 26 Feb 2024 | 5,000 | 8,570 (0%) | 0% | 30.2 | 151,050 | Common Stock |
| Frank Mottola | SVP, Quality, GMP, Ops, IT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 1,875 | 8,186 (0%) | 0% | 0 | Common Stock | |
| C. Dec Timothy | Senior Vice-President & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 2,500 | 8,504 (0%) | 0% | 0 | Common Stock | |
| Tami Martin Tillotson | Sr. V.P., Regulatory Affairs | 23 Feb 2024 | 485 | 86,933 (0%) | 0% | 29.1 | 14,094 | Common Stock | |
| M. John Siebert | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Feb 2024 | 3,886 | 0 | - | - | Restricted Stock Unit | |
| Tillotson Tami Martin | Sr. V.P., Regulatory Affairs | 23 Feb 2024 | 1,250 | 87,418 (0%) | 0% | 0 | Common Stock | ||
| Frederick Hudson M. | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Feb 2024 | 3,886 | 0 | - | - | Restricted Stock Unit | |
| Gemayel Georges | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 3,886 | 17,201 (0%) | 0% | 0 | Common Stock | |
| Padmanabh Bhatt P. | Sr. VP of IP, CSO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.06 per share. | 23 Feb 2024 | 638 | 8,570 (0%) | 0% | 29.1 | 18,540 | Common Stock |
| Rubin Jonathan | SVP, Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Feb 2024 | 1,250 | 3,750 | - | - | Restricted Stock Unit | |
| C. Timothy Dec | Senior Vice-President & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.06 per share. | 23 Feb 2024 | 1,314 | 7,190 (0%) | 0% | 29.1 | 38,185 | Common Stock |
| Rubin Jonathan | SVP, Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.06 per share. | 23 Feb 2024 | 567 | 4,641 (0%) | 0% | 29.1 | 16,477 | Common Stock |
| Carrolee Barlow | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Feb 2024 | 3,886 | 0 | - | - | Restricted Stock Units | |
| Bhatt P. Padmanabh | Sr. VP of IP, CSO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Feb 2024 | 1,250 | 3,750 | - | - | Restricted Stock Unit | |
| P. Bhatt Padmanabh | Sr. VP of IP, CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 1,250 | 9,208 (0%) | 0% | 0 | Common Stock | |
| Frank Mottola | SVP, Quality, GMP, Ops, IT | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Feb 2024 | 1,875 | 5,625 | - | - | Restricted Stock Unit | |
| Charles Newhall W. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 3,886 | 120,975 (0%) | 0% | 0 | Common Stock | |
| M. Siebert John | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 3,886 | 87,943 (0%) | 0% | 0 | Common Stock | |
| Mottola Frank | SVP, Quality, GMP, Ops, IT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.06 per share. | 23 Feb 2024 | 937 | 7,249 (0%) | 0% | 29.1 | 27,229 | Common Stock |
| Gemayel Georges | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Feb 2024 | 3,886 | 0 | - | - | Restricted Stock Unit | |
| Tillotson Martin Tami | Sr. V.P., Regulatory Affairs | 23 Feb 2024 | 1,250 | 3,750 | - | - | Restricted Stock Unit | ||
| Dec C. Timothy | Senior Vice-President & CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Feb 2024 | 2,500 | 7,500 | - | - | Restricted Stock Unit | |
| W. Charles Newhall | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Feb 2024 | 3,886 | 0 | - | - | Restricted Stock Unit | |
| Carrolee Barlow | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 3,886 | 17,201 (0%) | 0% | 0 | Common Stock | |
| Hudson Frederick M. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 3,886 | 37,117 (0%) | 0% | 0 | Common Stock | |
| Rubin Jonathan | SVP, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 1,250 | 5,208 (0%) | 0% | 0 | Common Stock | |
| M. Hudson Frederick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 5,369 | 5,369 | - | - | Restricted Stock Units | |
| Tami Tillotson Martin | Sr. V.P., Regulatory Affairs | 22 Feb 2024 | 246 | 86,168 (0%) | 0% | 27.9 | 6,873 | Common Stock | |
| Frank Mottola | SVP, Quality, GMP, Ops, IT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 5,000 | 5,000 | - | - | Restricted Stock Unit | |
| Mottola Frank | SVP, Quality, GMP, Ops, IT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 990 | 990 | - | - | Performance Share Unit | |
| Tillotson Martin Tami | Sr. V.P., Regulatory Affairs | 22 Feb 2024 | 750 | 1,500 | - | - | Restricted Stock Units | ||
| Jonathan Rubin | SVP, Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.94 per share. | 22 Feb 2024 | 303 | 3,958 (0%) | 0% | 27.9 | 8,466 | Common Stock |
| Frank Mottola | SVP, Quality, GMP, Ops, IT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.94 per share. | 22 Feb 2024 | 335 | 6,311 (0%) | 0% | 27.9 | 9,360 | Common Stock |
| M. John Siebert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 8,252 | 8,252 | - | - | Director Stock Option (Right to Buy) | |
| W. Charles Newhall | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 5,369 | 5,369 | - | - | Restricted Stock Units | |
| Timothy Dec C. | Senior Vice-President & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 50,000 | 50,000 | - | - | Employee Stock Option (Right to Buy) | |
| C. Timothy Dec | Senior Vice-President & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 12,000 | 12,000 | - | - | Restricted Stock Unit | |
| M. Siebert John | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 5,369 | 5,369 | - | - | Restricted Stock Units | |
| Barlow Carrolee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 5,369 | 5,369 | - | - | Restricted Stock Units | |
| Bhatt Padmanabh P. | Sr. VP of IP, CSO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Feb 2024 | 750 | 1,500 | - | - | Restricted Stock Unit | |
| Padmanabh Bhatt P. | Sr. VP of IP, CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 750 | 8,330 (0%) | 0% | 0 | Common Stock | |
| Sensenig Bethany | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 5,369 | 5,369 | - | - | Restricted Stock Units | |
| Rubin Jonathan | SVP, Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Feb 2024 | 750 | 1,500 | - | - | Restricted Stock Unit | |
| Gemayel Georges | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 8,252 | 8,252 | - | - | Director Stock Option (Right to Buy) | |
| P. Bhatt Padmanabh | Sr. VP of IP, CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 20,000 | 20,000 | - | - | Employee Stock Option (Right to Buy) | |
| W. Charles Newhall | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 8,252 | 8,252 | - | - | Director Stock Option (Right to Buy) | |
| Mottola Frank | SVP, Quality, GMP, Ops, IT | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Feb 2024 | 750 | 1,500 | - | - | Restricted Stock Unit | |
| Bethany Sensenig | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 8,252 | 8,252 | - | - | Director Stock Option (Right to Buy) | |
| Rubin Jonathan | SVP, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 25,000 | 25,000 | - | - | Employee Stock Option (Right to Buy) | |
| Frederick M. Hudson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 8,252 | 8,252 | - | - | Director Stock Option (Right to Buy) | |
| Jack Khattar A. | Director, President, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 322,000 | 322,000 | - | - | Employee Stock Option (Right to Buy) | |
| P. Padmanabh Bhatt | Sr. VP of IP, CSO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.94 per share. | 22 Feb 2024 | 372 | 7,958 (0%) | 0% | 27.9 | 10,394 | Common Stock |
| Georges Gemayel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 5,369 | 5,369 | - | - | Restricted Stock Units | |
| Dec C. Timothy | Senior Vice-President & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 500 | 6,004 (0%) | 0% | 0 | Common Stock | |
| P. Padmanabh Bhatt | Sr. VP of IP, CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 5,000 | 5,000 | - | - | Restricted Stock Unit | |
| C. Dec Timothy | Senior Vice-President & CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Feb 2024 | 500 | 1,000 | - | - | Restricted Stock Unit | |
| Mottola Frank | SVP, Quality, GMP, Ops, IT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 25,000 | 25,000 | - | - | Employee Stock Option (Right to Buy) | |
| Carrolee Barlow | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 8,252 | 8,252 | - | - | Director Stock Option (Right to Buy) | |
| Jonathan Rubin | SVP, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 5,000 | 5,000 | - | - | Restricted Stock Unit | |
| Frank Mottola | SVP, Quality, GMP, Ops, IT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 750 | 6,646 (0%) | 0% | 0 | Common Stock | |
| A. Khattar Jack | Director, President, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 35,000 | 35,000 | - | - | Performance Share Unit | |
| Rubin Jonathan | SVP, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 750 | 4,261 (0%) | 0% | 0 | Common Stock | |
| Martin Tillotson Tami | Sr. V.P., Regulatory Affairs | 22 Feb 2024 | 750 | 86,414 (0%) | 0% | 0 | Common Stock | ||
| A. Khattar Jack | Director, President, CEO | Other type of transaction at price $ 0.00 per share. | 12 Feb 2024 | 16,500 | 897,005 (1%) | 0% | - | Common Stock | |
| Jack A. Khattar | Director, President, CEO | Other type of transaction at price $ 0.00 per share. | 12 Feb 2024 | 16,500 | 1,022,450 (1%) | 0% | - | Common Stock | |
| Martin Tami Tillotson | Sr. V.P., Regulatory Affairs | 10 Jan 2024 | 8,000 | 0 | - | - | Employee Stock Option (Right to Buy) | ||
| Martin Tami Tillotson | Sr. V.P., Regulatory Affairs | 10 Jan 2024 | 8,000 | 85,664 (0%) | 0% | 27.9 | 223,280 | Common Stock | |
| Tami Martin Tillotson | Sr. V.P., Regulatory Affairs | 10 Jan 2024 | 8,000 | 93,664 (0%) | 0% | 9.2 | 73,920 | Common Stock | |
| A. Khattar Jack | Director, President, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.66 per share. | 22 Dec 2023 | 11,958 | 880,505 (1%) | 0% | 27.7 | 330,758 | Common Stock |
| Jonathan Rubin | Sr. VP, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Dec 2023 | 600 | 0 | - | - | Performance Share Unit | |
| A. Jack Khattar | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Dec 2023 | 25,000 | 0 | - | - | Performance Share Unit | |
| Jonathan Rubin | Sr. VP, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Dec 2023 | 600 | 3,447 (0%) | 0% | 0 | Common Stock | |
| Jonathan Rubin | Sr. VP, Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.66 per share. | 22 Dec 2023 | 204 | 3,243 (0%) | 0% | 27.7 | 5,643 | Common Stock |
| A. Khattar Jack | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Dec 2023 | 25,000 | 892,463 (1%) | 0% | 0 | Common Stock | |
| Khattar A. Jack | Director, President, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2023 | 25,000 | 25,000 | - | - | Performance Share Unit | |
| Rubin Jonathan | SVP, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2023 | 600 | 600 | - | - | Performance Share Unit | |
| Tami Tillotson Martin | Sr. V.P., Regulatory Affairs | 25 Aug 2023 | 5,135 | 85,249 (0%) | 0% | 31.6 | 162,215 | Common Stock | |
| Jack A. Khattar | Director, President, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Aug 2023 | 35,000 | 35,000 | - | - | Performance Share Unit | |
| Padmanabh P. Bhatt | Sr. VP of IP, CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Aug 2023 | 2,500 | 2,500 | - | - | Performance Share Unit | |
| Bethany Sensenig | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Aug 2023 | 24,153 | 24,153 | - | - | Director Stock Option (Right to Buy) | |
| Timothy C. Dec | Senior Vice-President & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.47 per share. | 11 May 2023 | 709 | 2,650 (0%) | 0% | 36.5 | 25,857 | Common Stock |
| Timothy C. Dec | Senior Vice-President & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 May 2023 | 1,500 | 3,359 (0%) | 0% | 0 | Common Stock | |
| Timothy C. Dec | Senior Vice-President & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 May 2023 | 1,500 | 0 | - | - | Performance Share Units | |
| Jack A. Khattar | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 May 2023 | 31,250 | 864,272 (1%) | 0% | 0 | Common Stock | |
| Jack A. Khattar | Director, President, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.47 per share. | 11 May 2023 | 15,005 | 849,267 (1%) | 0% | 36.5 | 547,232 | Common Stock |
| Jack A. Khattar | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 May 2023 | 31,250 | 0 | - | - | Performance Share Unit | |
| Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 May 2023 | 750 | 5,497 (0%) | 0% | 0 | Common Stock | |
| Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 May 2023 | 750 | 0 | - | - | Performance Share Unit | |
| Timothy C. Dec | Senior Vice-President & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2023 | 1,500 | 1,500 | - | - | Performance Share Units | |
| Jack A. Khattar | Director, President, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2023 | 31,250 | 31,250 | - | - | Performance Share Unit | |
| Padmanabh P. Bhatt | Sr. VP of IP, CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2023 | 750 | 750 | - | - | Performance Share Unit | |
| Padmanabh P. Bhatt | Sr. VP of IP, CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Apr 2023 | 1,500 | 4,747 (0%) | 0% | 0 | Common Stock | |
| Timothy C. Dec | Senior Vice-President & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.65 per share. | 14 Mar 2023 | 789 | 2,052 (0%) | 0% | 38.7 | 30,495 | Common Stock |
| Timothy C. Dec | Senior Vice-President & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Mar 2023 | 1,500 | 0 | - | - | Performance Share Unit | |
| Timothy C. Dec | Senior Vice-President & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Mar 2023 | 1,500 | 2,841 (0%) | 0% | 0 | Common Stock | |
| Jack A. Khattar | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Mar 2023 | 20,000 | 0 | - | - | Performance Share Unit | |
| Jack A. Khattar | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Mar 2023 | 20,000 | 833,022 (1%) | 0% | 0 | Common Stock | |
| Frank Mottola | Sr VP, Quality, GMP Oper. & IT | Sale of securities on an exchange or to another person at price $ 35.99 per share. | 14 Mar 2023 | 4,780 | 4,737 (0%) | 0% | 36.0 | 172,023 | Common Stock |
| Charles W. Newhall | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 3,886 | 3,886 | - | - | Restricted Stock Units | |
| Charles W. Newhall | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 6,293 | 6,293 | - | - | Director Stock Option (Right to Buy) | |
| Frederick M. Hudson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 6,293 | 6,293 | - | - | Director Stock Option (Right to Buy) | |
| Frederick M. Hudson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 3,886 | 3,886 | - | - | Restricted Stock Units | |
| Georges Gemayel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 6,293 | 6,293 | - | - | Director Stock Option (Right to Buy) | |
| Georges Gemayel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 3,886 | 3,886 | - | - | Restricted Stock Units | |
| Timothy C. Dec | Senior Vice-President & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 10,000 | 10,000 | - | - | Restricted Stock Units | |
| Timothy C. Dec | Senior Vice-President & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 40,000 | 40,000 | - | - | Employee Stock Option (Right to Buy) | |
| John M. Siebert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 6,293 | 6,293 | - | - | Director Stock Option (Right to Buy) | |
| John M. Siebert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 3,886 | 3,886 | - | - | Restricted Stock Units | |
| Jack A. Khattar | Director, President, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 280,000 | 280,000 | - | - | Employee Stock Option (Right to Buy) | |
| Padmanabh P. Bhatt | Sr. VP of IP, CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 5,000 | 5,000 | - | - | Restricted Stock Units | |
| Padmanabh P. Bhatt | Sr. VP of IP, CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 20,000 | 20,000 | - | - | Employee Stock Option (Right to Buy) | |
| Tami Tillotson Martin | Sr. V.P., Regulatory Affairs | 23 Feb 2023 | 5,000 | 5,000 | - | - | Restricted Stock Units | ||
| Tami Tillotson Martin | Sr. V.P., Regulatory Affairs | 23 Feb 2023 | 20,000 | 20,000 | - | - | Employee Stock Option (Right to Buy) | ||
| Jonathan Rubin | SVP, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 5,000 | 5,000 | - | - | Restricted Stock Units | |
| Jonathan Rubin | SVP, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 20,000 | 20,000 | - | - | Employee Stock Option (Right to Buy) | |
| Carrolee Barlow | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 6,293 | 6,293 | - | - | Director Stock Option (Right to Buy) | |
| Carrolee Barlow | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 3,886 | 3,886 | - | - | Restricted Stock Units | |
| Frank Mottola | SVP, Quality, GMP, Ops, IT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 7,500 | 7,500 | - | - | Restricted Stock Units | |
| Frank Mottola | SVP, Quality, GMP, Ops, IT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 30,000 | 30,000 | - | - | Employee Stock Option (Right to Buy) | |
| Charles W. Newhall | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2023 | 3,882 | 112,132 (0%) | 0% | 0 | Common Stock | |
| Charles W. Newhall | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Feb 2023 | 3,882 | 0 | - | - | Restricted Stock Units | |
| Frederick M. Hudson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2023 | 3,882 | 34,867 (0%) | 0% | 0 | Common Stock | |
| Frederick M. Hudson | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Feb 2023 | 3,882 | 0 | - | - | Restricted Stock Units | |
| Georges Gemayel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2023 | 3,882 | 13,315 (0%) | 0% | 0 | Common Stock | |
| Georges Gemayel | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Feb 2023 | 3,882 | 0 | - | - | Restricted Stock Units | |
| Timothy C. Dec | Senior Vice-President & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.57 per share. | 22 Feb 2023 | 193 | 1,148 (0%) | 0% | 38.6 | 7,444 | Common Stock |
| Timothy C. Dec | Senior Vice-President & CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Feb 2023 | 500 | 1,500 | - | - | Restricted Stock Units | |
| Timothy C. Dec | Senior Vice-President & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2023 | 500 | 1,341 (0%) | 0% | 0 | Common Stock | |
| John M. Siebert | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Feb 2023 | 3,882 | 0 | - | - | Restricted Stock Units | |
| John M. Siebert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2023 | 3,882 | 84,057 (0%) | 0% | 0 | Common Stock | |
| Padmanabh P. Bhatt | Sr. VP of IP, CSO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Feb 2023 | 750 | 2,250 | - | - | Restricted Stock Units | |
| Padmanabh P. Bhatt | Sr. VP of IP, CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2023 | 750 | 3,247 (0%) | 0% | 0 | Common Stock | |
| Tami Tillotson Martin | Sr. V.P., Regulatory Affairs | 22 Feb 2023 | 750 | 90,323 (0%) | 0% | 0 | Common Stock | ||
| Tami Tillotson Martin | Sr. V.P., Regulatory Affairs | 22 Feb 2023 | 750 | 2,250 | - | - | Restricted Stock Units | ||
| Tami Tillotson Martin | Sr. V.P., Regulatory Affairs | 22 Feb 2023 | 289 | 90,034 (0%) | 0% | 38.6 | 11,147 | Common Stock | |
| Jonathan Rubin | SVP, Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Feb 2023 | 750 | 2,250 | - | - | Restricted Stock Units | |
| Jonathan Rubin | SVP, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2023 | 750 | 2,497 (0%) | 0% | 0 | Common Stock | |
| Carrolee Barlow | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Feb 2023 | 3,882 | 0 | - | - | Restricted Stock Units | |
| Carrolee Barlow | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2023 | 3,882 | 13,315 (0%) | 0% | 0 | Common Stock | |
| Frank Mottola | Sr VP, Quality, GMP Oper. & IT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2023 | 750 | 9,517 (0%) | 0% | 0 | Common Stock | |
| Frank Mottola | Sr VP, Quality, GMP Oper. & IT | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Feb 2023 | 750 | 2,250 | - | - | Restricted Stock Units | |
| Frank Mottola | Sr VP, Quality, GMP Oper. & IT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.57 per share. | 22 Feb 2023 | 289 | 9,228 (0%) | 0% | 38.6 | 11,147 | Common Stock |
| Timothy C. Dec | Senior Vice-President & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 1,500 | 1,500 | - | - | Performance Share Unit | |
| Jack A. Khattar | Director, President, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 20,000 | 20,000 | - | - | Performance Share Unit | |
| Tami Tillotson Martin | Sr. V.P., Regulatory Affairs | 16 Feb 2023 | 1,500 | 0 | - | - | Performance Share Unit | ||
| Tami Tillotson Martin | Sr. V.P., Regulatory Affairs | 16 Feb 2023 | 1,500 | 88,720 (0%) | 0% | 0 | Common Stock | ||
| Jonathan Rubin | SVP, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2023 | 1,500 | 1,500 (0%) | 0% | 0 | Common Stock | |
| Jonathan Rubin | SVP, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2023 | 1,500 | 0 | - | - | Performance Share Unit | |
| Frank Mottola | SVP, Quality, GMP, Ops, IT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.74 per share. | 16 Feb 2023 | 753 | 8,191 (0%) | 0% | 38.7 | 29,171 | Common Stock |
| Frank Mottola | SVP, Quality, GMP, Ops, IT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2023 | 1,500 | 8,944 (0%) | 0% | 0 | Common Stock | |
| Frank Mottola | SVP, Quality, GMP, Ops, IT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2023 | 1,500 | 0 | - | - | Performance Share Unit | |
| Jack A. Khattar | Director, President, CEO | Other type of transaction at price $ 0.00 per share. | 15 Feb 2023 | 8,750 | 1,038,950 (1%) | 0% | - | Common Stock | |
| Jack A. Khattar | Director, President, CEO | Other type of transaction at price $ 0.00 per share. | 15 Feb 2023 | 8,750 | 813,022 (1%) | 0% | - | Common Stock | |
| Jack A. Khattar | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.56 per share. | 02 Feb 2023 | 22,515 | 817,674 (1%) | 0% | 9.6 | 215,243 | Common Stock |
| Jack A. Khattar | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2023 | 330 | 25,037 | - | - | Employee Stock Option (Right to Buy) | |
| Jack A. Khattar | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2023 | 22,515 | 25,367 | - | - | Employee Stock Option (Right to Buy) | |
| Jack A. Khattar | Director, President, CEO | Sale of securities on an exchange or to another person at price $ 42.02 per share. | 02 Feb 2023 | 200 | 804,272 (1%) | 0% | 42.0 | 8,404 | Common Stock |
| Jack A. Khattar | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.56 per share. | 02 Feb 2023 | 330 | 804,472 (1%) | 0% | 9.6 | 3,155 | Common Stock |
| Jack A. Khattar | Director, President, CEO | Sale of securities on an exchange or to another person at price $ 42.05 per share. | 02 Feb 2023 | 13,532 | 804,142 (1%) | 0% | 42.1 | 569,088 | Common Stock |
| Jack A. Khattar | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2023 | 498 | 47,882 | - | - | Employee Stock Option (Right to Buy) | |
| Jack A. Khattar | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.56 per share. | 01 Feb 2023 | 498 | 795,459 (1%) | 0% | 9.6 | 4,761 | Common Stock |
| Jack A. Khattar | Director, President, CEO | Sale of securities on an exchange or to another person at price $ 42.01 per share. | 01 Feb 2023 | 300 | 795,159 (1%) | 0% | 42.0 | 12,602 | Common Stock |
| Jack A. Khattar | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2023 | 1,620 | 48,380 | - | - | Employee Stock Option (Right to Buy) | |
| Jack A. Khattar | Director, President, CEO | Sale of securities on an exchange or to another person at price $ 42.01 per share. | 31 Jan 2023 | 976 | 794,961 (1%) | 0% | 42.0 | 41,002 | Common Stock |
| Jack A. Khattar | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.56 per share. | 31 Jan 2023 | 1,620 | 795,937 (1%) | 0% | 9.6 | 15,487 | Common Stock |
| Jack A. Khattar | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.56 per share. | 18 Jan 2023 | 8,080 | 799,253 (1%) | 0% | 9.6 | 77,245 | Common Stock |
| Jack A. Khattar | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jan 2023 | 8,080 | 50,000 | - | - | Employee Stock Option (Right to Buy) | |
| Jack A. Khattar | Director, President, CEO | Sale of securities on an exchange or to another person at price $ 40.40 per share. | 18 Jan 2023 | 4,936 | 794,317 (1%) | 0% | 40.4 | 199,394 | Common Stock |
| Jack A. Khattar | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.56 per share. | 17 Jan 2023 | 41,920 | 816,619 (1%) | 0% | 9.6 | 400,755 | Common Stock |
| Jack A. Khattar | Director, President, CEO | Sale of securities on an exchange or to another person at price $ 40.03 per share. | 17 Jan 2023 | 25,446 | 791,173 (1%) | 0% | 40.0 | 1,018,728 | Common Stock |
| Jack A. Khattar | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2023 | 41,920 | 58,080 | - | - | Employee Stock Option (Right to Buy) | |
| Padmanabh P. Bhatt | Sr. VP of IP, CSO | Sale of securities on an exchange or to another person at price $ 39.92 per share. | 17 Jan 2023 | 4,826 | 1,644 (0%) | 0% | 39.9 | 192,638 | Common Stock |
| Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2023 | 4,826 | 5,000 | - | - | Employee Stock Option (Right to Buy) | |
| Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.13 per share. | 17 Jan 2023 | 4,826 | 6,470 (0%) | 0% | 9.1 | 44,061 | Common Stock |
| Tami Tillotson Martin | Sr. V.P., Regulatory Affairs | 12 Jan 2023 | 1,500 | 1,500 | - | - | Performance Share Unit | ||
| Jonathan Rubin | Sr. VP, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2023 | 1,500 | 1,500 | - | - | Performance Share Unit | |
| Frank Mottola | SVP, Quality, GMP, Ops, IT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2023 | 1,500 | 1,500 | - | - | Performance Share Unit | |
| Frederick M. Hudson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.90 per share. | 10 Jan 2023 | 8,722 | 30,985 (0%) | 0% | 7.9 | 68,904 | Common Stock |
| Frederick M. Hudson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jan 2023 | 8,722 | 0 | - | - | Director Stock Option (Right to Buy) | |
| Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2023 | 174 | 9,826 | - | - | Employee Stock Option (Right to Buy) | |
| Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.13 per share. | 06 Jan 2023 | 174 | 1,818 (0%) | 0% | 9.1 | 1,589 | Common Stock |
| Padmanabh P. Bhatt | Sr. VP of IP, CSO | Sale of securities on an exchange or to another person at price $ 39.90 per share. | 06 Jan 2023 | 174 | 1,644 (0%) | 0% | 39.9 | 6,943 | Common Stock |
| Charles W. Newhall | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2022 | 2,203 | 108,250 (0%) | 0% | 0 | Common Stock | |
| Charles W. Newhall | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Dec 2022 | 8,722 | 0 | - | - | Director Stock Option (Right to Buy) | |
| Charles W. Newhall | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.90 per share. | 28 Dec 2022 | 8,722 | 110,453 (0%) | 0% | 7.9 | 68,904 | Common Stock |
| Jack A. Khattar | Director, President, CEO | Sale of securities on an exchange or to another person at price $ 38.14 per share. | 20 Dec 2022 | 11,354 | 814,699 (1%) | 0% | 38.1 | 433,070 | Common Stock |
| Jack A. Khattar | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.56 per share. | 20 Dec 2022 | 18,472 | 826,053 (1%) | 0% | 9.6 | 176,592 | Common Stock |
| Jack A. Khattar | Director, President, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2022 | 15,625 | 807,581 (1%) | 0% | 0 | Common Stock | |
| Jack A. Khattar | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.56 per share. | 20 Dec 2022 | 6,528 | 795,962 (1%) | 0% | 9.6 | 62,408 | Common Stock |
| Jack A. Khattar | Director, President, CEO | Sale of securities on an exchange or to another person at price $ 38.02 per share. | 20 Dec 2022 | 4,006 | 791,956 (1%) | 0% | 38.0 | 152,317 | Common Stock |
| Jack A. Khattar | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Dec 2022 | 18,472 | 100,000 | - | - | Employee Stock Option (Right to Buy) | |
| Jack A. Khattar | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Dec 2022 | 6,528 | 118,472 | - | - | Employee Stock Option (Right to Buy) | |
| Padmanabh P. Bhatt | Sr. VP of IP, CSO | Sale of securities on an exchange or to another person at price $ 37.48 per share. | 01 Dec 2022 | 5,000 | 1,644 (0%) | 0% | 37.5 | 187,416 | Common Stock |
| Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2022 | 5,000 | 10,000 | - | - | Employee Stock Option (Right to Buy) | |
| Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.13 per share. | 01 Dec 2022 | 5,000 | 6,644 (0%) | 0% | 9.1 | 45,650 | Common Stock |
| Jack A. Khattar | Director, President, CEO | Sale of securities on an exchange or to another person at price $ 35.05 per share. | 23 Nov 2022 | 2,259 | 782,775 (1%) | 0% | 35.1 | 79,189 | Common Stock |
| Jack A. Khattar | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Nov 2022 | 17,794 | 125,000 | - | - | Employee Stock Option (Right to Buy) | |
| Jack A. Khattar | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Nov 2022 | 3,616 | 142,794 | - | - | Employee Stock Option (Right to Buy) | |
| Jack A. Khattar | Director, President, CEO | Sale of securities on an exchange or to another person at price $ 35.18 per share. | 23 Nov 2022 | 11,135 | 789,434 (1%) | 0% | 35.2 | 391,685 | Common Stock |
| Jack A. Khattar | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.56 per share. | 23 Nov 2022 | 17,794 | 800,569 (1%) | 0% | 9.6 | 170,111 | Common Stock |
| Jack A. Khattar | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.56 per share. | 23 Nov 2022 | 3,616 | 785,034 (1%) | 0% | 9.6 | 34,569 | Common Stock |
| Jack A. Khattar | Director, President, CEO | Sale of securities on an exchange or to another person at price $ 35.00 per share. | 22 Nov 2022 | 600 | 781,418 (1%) | 0% | 35.0 | 21,001 | Common Stock |
| Jack A. Khattar | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Nov 2022 | 959 | 146,410 | - | - | Employee Stock Option (Right to Buy) | |
| Jack A. Khattar | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.56 per share. | 22 Nov 2022 | 959 | 782,018 (1%) | 0% | 9.6 | 9,168 | Common Stock |
| Jack A. Khattar | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2022 | 848 | 147,369 | - | - | Employee Stock Option (Right to Buy) | |
| Jack A. Khattar | Director, President, CEO | Sale of securities on an exchange or to another person at price $ 35.01 per share. | 21 Nov 2022 | 531 | 781,059 (1%) | 0% | 35.0 | 18,592 | Common Stock |
| Jack A. Khattar | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.56 per share. | 21 Nov 2022 | 848 | 781,590 (1%) | 0% | 9.6 | 8,107 | Common Stock |
| Jack A. Khattar | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.56 per share. | 15 Nov 2022 | 1,783 | 781,857 (1%) | 0% | 9.6 | 17,045 | Common Stock |
| Jack A. Khattar | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2022 | 1,783 | 148,217 | - | - | Employee Stock Option (Right to Buy) | |
| Jack A. Khattar | Director, President, CEO | Sale of securities on an exchange or to another person at price $ 35.00 per share. | 15 Nov 2022 | 1,115 | 780,742 (1%) | 0% | 35.0 | 39,028 | Common Stock |
| Padmanabh P. Bhatt | Sr. VP of IP, CSO | Sale of securities on an exchange or to another person at price $ 34.95 per share. | 11 Nov 2022 | 6,800 | 1,644 (0%) | 0% | 34.9 | 237,655 | Common Stock |
| Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Nov 2022 | 6,800 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.24 per share. | 11 Nov 2022 | 6,800 | 8,444 (0%) | 0% | 9.2 | 62,832 | Common Stock |
| Padmanabh P. Bhatt | Sr. VP of IP, CSO | Sale of securities on an exchange or to another person at price $ 34.97 per share. | 09 Nov 2022 | 700 | 1,644 (0%) | 0% | 35.0 | 24,480 | Common Stock |
| Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Nov 2022 | 700 | 6,800 | - | - | Employee Stock Option (Right to Buy) | |
| Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.24 per share. | 09 Nov 2022 | 700 | 2,344 (0%) | 0% | 9.2 | 6,468 | Common Stock |
| Jack A. Khattar | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 33.75 per share. | 14 Sep 2022 | 1,380 | 780,074 (1%) | 0% | 33.8 | 46,575 | Common Stock |
| Jack A. Khattar | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Sep 2022 | 5,895 | 0 | - | - | Stock Appreciation Right | |
| Jack A. Khattar | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Sep 2022 | 5,895 | 781,454 (1%) | 0% | 0 | Common Stock | |
| Tami Tillotson Martin | Sr. V.P., Regulatory Affairs | 22 Aug 2022 | 5,000 | 87,220 (0%) | 0% | 36.0 | 179,900 | Common Stock | |
| Tami Tillotson Martin | Sr. V.P., Regulatory Affairs | 22 Aug 2022 | 5,000 | 0 | - | - | Employee Stock Option (Right to Buy) | ||
| Tami Tillotson Martin | Sr. V.P., Regulatory Affairs | 22 Aug 2022 | 5,000 | 92,220 (0%) | 0% | 7.9 | 39,500 | Common Stock | |
| Jack A. Khattar | Director, President, CEO | Sale of securities on an exchange or to another person at price $ 34.01 per share. | 16 Aug 2022 | 14,690 | 775,559 (1%) | 0% | 34.0 | 499,651 | Common Stock |
| Jack A. Khattar | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Aug 2022 | 39,530 | 5,895 | - | - | Stock Appreciation Right | |
| Jack A. Khattar | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Aug 2022 | 39,530 | 799,431 (1%) | 0% | 0 | Common Stock | |
| Jack A. Khattar | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 34.01 per share. | 16 Aug 2022 | 9,182 | 790,249 (1%) | 0% | 34.0 | 312,307 | Common Stock |
| Jack A. Khattar | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 34.03 per share. | 15 Aug 2022 | 10,813 | 777,203 (1%) | 0% | 34.0 | 367,945 | Common Stock |
| Jack A. Khattar | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2022 | 46,575 | 788,016 (1%) | 0% | 0 | Common Stock | |
| Jack A. Khattar | Director, President, CEO | Sale of securities on an exchange or to another person at price $ 34.03 per share. | 15 Aug 2022 | 17,302 | 759,901 (1%) | 0% | 34.0 | 588,752 | Common Stock |
| Jack A. Khattar | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2022 | 46,575 | 45,425 | - | - | Stock Appreciation Right | |
| Jack A. Khattar | Director, President, CEO | Sale of securities on an exchange or to another person at price $ 31.22 per share. | 10 Aug 2022 | 28,437 | 741,441 (1%) | 0% | 31.2 | 887,803 | Common Stock |
| Jack A. Khattar | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Aug 2022 | 44,900 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Jack A. Khattar | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Aug 2022 | 44,900 | 769,878 (1%) | 0% | 0 | Common Stock | |
| Jack A. Khattar | Director, President, CEO | Sale of securities on an exchange or to another person at price $ 31.15 per share. | 09 Aug 2022 | 39,431 | 724,978 (1%) | 0% | 31.2 | 1,228,276 | Common Stock |
| Jack A. Khattar | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Aug 2022 | 63,100 | 764,409 (1%) | 0% | 0 | Common Stock | |
| Jack A. Khattar | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Aug 2022 | 63,100 | 44,900 | - | - | Employee Stock Option (Right to Buy) | |
| Jack A. Khattar | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Aug 2022 | 192,000 | 819,216 (1%) | 0% | 0 | Common Stock | |
| Jack A. Khattar | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Aug 2022 | 192,000 | 108,000 | - | - | Employee Stock Option (Right to Buy) | |
| Jack A. Khattar | Director, President, CEO | Sale of securities on an exchange or to another person at price $ 32.11 per share. | 08 Aug 2022 | 10,032 | 701,309 (1%) | 0% | 32.1 | 322,128 | Common Stock |
| Jack A. Khattar | Director, President, CEO | Sale of securities on an exchange or to another person at price $ 31.40 per share. | 08 Aug 2022 | 107,875 | 711,341 (1%) | 0% | 31.4 | 3,387,275 | Common Stock |
| Tami Tillotson Martin | Sr. V.P., Regulatory Affairs | 04 Aug 2022 | 5,000 | 92,220 (0%) | 0% | 7.9 | 39,500 | Common Stock | |
| Tami Tillotson Martin | Sr. V.P., Regulatory Affairs | 04 Aug 2022 | 5,000 | 5,000 | - | - | Employee Stock Option (Right to Buy) | ||
| Tami Tillotson Martin | Sr. V.P., Regulatory Affairs | 04 Aug 2022 | 5,000 | 87,220 (0%) | 0% | 33.0 | 164,900 | Common Stock | |
| Padmanabh P. Bhatt | Sr. VP of IP, CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2022 | 750 | 1,644 (0%) | 0% | 0 | Common Stock | |
| Jack A. Khattar | Director, President, CEO | Other type of transaction at price $ 0.00 per share. | 18 Mar 2022 | 10,750 | 1,047,700 (1%) | 0% | - | Common Stock | |
| Jack A. Khattar | Director, President, CEO | Other type of transaction at price $ 0.00 per share. | 18 Mar 2022 | 10,750 | 627,216 (1%) | 0% | - | Common Stock | |
| Jack A. Khattar | Director, President, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2022 | 20,000 | 576,466 (1%) | 0% | 0 | Common Stock | |
| Jack A. Khattar | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Mar 2022 | 40,000 | 0 | - | - | Performance Share Unit | |
| Jack A. Khattar | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Mar 2022 | 40,000 | 556,466 (1%) | 0% | 0 | Common Stock | |
| Charles W. Newhall | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2022 | 3,882 | 3,882 | - | - | Restricted Stock Units | |
| Charles W. Newhall | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2022 | 6,847 | 6,847 | - | - | Director Stock Option (Right to Buy) | |
| Frederick M. Hudson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2022 | 3,882 | 3,882 | - | - | Restricted Stock Units | |
| Frederick M. Hudson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2022 | 6,847 | 6,847 | - | - | Director Stock Option (Right to Buy) | |
| Georges Gemayel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2022 | 3,882 | 3,882 | - | - | Restricted Stock Units | |
| Georges Gemayel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2022 | 6,847 | 6,847 | - | - | Director Stock Option (Right to Buy) | |
| Timothy C. Dec | Senior Vice-President & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2022 | 25,000 | 25,000 | - | - | Employee Stock Option (Right to Buy) | |
| Timothy C. Dec | Senior Vice-President & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2022 | 2,000 | 2,000 | - | - | Restricted Stock Units | |
| John M. Siebert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2022 | 3,882 | 3,882 | - | - | Restricted Stock Units | |
| John M. Siebert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2022 | 6,847 | 6,847 | - | - | Director Stock Option (Right to Buy) | |
| Jack A. Khattar | Director, President, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2022 | 250,000 | 250,000 | - | - | Employee Stock Option (Right to Buy) | |
| Padmanabh P. Bhatt | Sr. VP of IP, CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2022 | 18,000 | 18,000 | - | - | Employee Stock Option (Right to Buy) | |
| Padmanabh P. Bhatt | Sr. VP of IP, CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2022 | 3,000 | 3,000 | - | - | Restricted Stock Units | |
| Tami Tillotson Martin | Sr. V.P., Regulatory Affairs | 22 Feb 2022 | 3,000 | 3,000 | - | - | Restricted Stock Units | ||
| Tami Tillotson Martin | Sr. V.P., Regulatory Affairs | 22 Feb 2022 | 18,000 | 18,000 | - | - | Employee Stock Option (Right to Buy) | ||
| Jonathan Rubin | SVP, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2022 | 25,000 | 25,000 | - | - | Employee Stock Option (Right to Buy) | |
| Jonathan Rubin | SVP, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2022 | 3,000 | 3,000 | - | - | Restricted Stock Units | |
| Carrolee Barlow | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2022 | 3,882 | 3,882 | - | - | Restricted Stock Units | |
| Carrolee Barlow | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2022 | 6,847 | 6,847 | - | - | Director Stock Option (Right to Buy) | |
| Frank Mottola | SVP, Quality, GMP, Ops, IT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2022 | 18,000 | 18,000 | - | - | Employee Stock Option (Right to Buy) | |
| Frank Mottola | SVP, Quality, GMP, Ops, IT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2022 | 3,000 | 3,000 | - | - | Restricted Stock Units | |
| Charles W. Newhall | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Feb 2022 | 4,222 | 0 | - | - | Restricted Stock Units | |
| Charles W. Newhall | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2022 | 4,222 | 101,731 (0%) | 0% | 0 | Common Stock | |
| Frederick M. Hudson | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Feb 2022 | 4,222 | 0 | - | - | Restricted Stock Units | |
| Frederick M. Hudson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2022 | 4,222 | 22,263 (0%) | 0% | 0 | Common Stock | |
| Georges Gemayel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2022 | 4,222 | 9,433 (0%) | 0% | 0 | Common Stock | |
| Georges Gemayel | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Feb 2022 | 4,222 | 0 | - | - | Restricted Stock Units | |
| John M. Siebert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2022 | 4,222 | 80,175 (0%) | 0% | 0 | Common Stock | |
| John M. Siebert | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Feb 2022 | 4,222 | 0 | - | - | Restricted Stock Units | |
| Carrolee Barlow | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2022 | 4,222 | 9,433 (0%) | 0% | 0 | Common Stock | |
| Carrolee Barlow | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Feb 2022 | 4,222 | 0 | - | - | Restricted Stock Units | |
| Timothy C. Dec | Senior Vice-President & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Aug 2021 | 85,000 | 85,000 | - | - | Employee Stock Option (Right to Buy) | |
| John M. Siebert | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.98 per share. | 11 Aug 2021 | 15,000 | 75,953 (0%) | 0% | 13.0 | 194,700 | Common Stock |
| John M. Siebert | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Aug 2021 | 15,000 | 0 | - | - | Director Stock Option (Right to Buy) | |
| Jack A. Khattar | Director, President, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2021 | 40,000 | 40,000 | - | - | Performance Share Unit | |
| Tami Tillotson Martin | Sr. V.P., Regulatory Affairs | 13 Apr 2021 | 3,125 | 6,250 | - | - | Employee Stock Option (Right to Buy) | ||
| Tami Tillotson Martin | Sr. V.P., Regulatory Affairs | 13 Apr 2021 | 3,125 | 89,451 (0%) | 0% | 13.0 | 40,563 | Common Stock | |
| Tami Tillotson Martin | Sr. V.P., Regulatory Affairs | 13 Apr 2021 | 3,125 | 86,326 (0%) | 0% | 30.0 | 93,702 | Common Stock | |
| Tami Tillotson Martin | Sr. V.P., Regulatory Affairs | 13 Apr 2021 | 3,125 | 89,451 (0%) | 0% | 13.0 | 40,563 | Common Stock | |
| Tami Tillotson Martin | Sr. V.P., Regulatory Affairs | 13 Apr 2021 | 3,125 | 86,326 (0%) | 0% | 32.0 | 99,938 | Common Stock | |
| Tami Tillotson Martin | Sr. V.P., Regulatory Affairs | 13 Apr 2021 | 3,125 | 9,375 | - | - | Employee Stock Option (Right to Buy) | ||
| Jack A. Khattar | Director, President, CEO | Other type of transaction at price $ 0.00 per share. | 26 Mar 2021 | 10,000 | 1,058,450 (2%) | 0% | - | Common Stock | |
| Jack A. Khattar | Director, President, CEO | Other type of transaction at price $ 0.00 per share. | 26 Mar 2021 | 10,000 | 516,466 (0%) | 0% | - | Common Stock | |
| Charles W. Newhall | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2021 | 7,365 | 7,365 | - | - | Director Stock Option (Right to Buy) | |
| Charles W. Newhall | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2021 | 4,222 | 4,222 | - | - | Restricted Stock Units | |
| Frederick M. Hudson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2021 | 7,365 | 7,365 | - | - | Director Stock Option (Right to Buy) | |
| Frederick M. Hudson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2021 | 4,222 | 4,222 | - | - | Restricted Stock Units | |
| Georges Gemayel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2021 | 4,222 | 4,222 | - | - | Restricted Stock Units | |
| Georges Gemayel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2021 | 7,365 | 7,365 | - | - | Director Stock Option (Right to Buy) | |
| John M. Siebert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2021 | 7,365 | 7,365 | - | - | Director Stock Option (Right to Buy) | |
| John M. Siebert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2021 | 4,222 | 4,222 | - | - | Restricted Stock Units | |
| Jack A. Khattar | Director, President, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2021 | 200,000 | 200,000 | - | - | Employee Stock Option (Right to Buy) | |
| James Kelly | Executive Vice-President & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2021 | 15,000 | 15,000 | - | - | Employee Stock Option (Right to Buy) | |
| Padmanabh P. Bhatt | Sr. VP of IP, CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2021 | 17,000 | 17,000 | - | - | Employee Stock Option (Right to Buy) | |
| Tami Tillotson Martin | Sr. V.P., Regulatory Affairs | 19 Feb 2021 | 17,000 | 17,000 | - | - | Employee Stock Option (Right to Buy) |